Civica

Rogue Theater Festival Present World Premiere Digital Production in Collaboration with Civica Scuola di Teatro Paolo Grassi and OnStage! Festival of American Theater

Retrieved on: 
Tuesday, June 14, 2022

NEW YORK, June 14, 2022 /PRNewswire/ -- The Rogue Theater Festival, New York City, in association with the Civica Scuola di Teatro Paolo Grassi in Milan, Italy announces production details of The Lantern Bearers by Marc Aronoff, a world premiere digital production. The Lantern Bearers is a one–act drama running 45-minutes which tells the story of the first two people on Earth and the "games" they play, revealing a modern parable that speaks to the human desire for change and the fears of stepping into an uncertain future. Described as "poignant and potent," the drama examines universal themes of feeling disconnected with ourselves and surroundings, exploring the essential and timely question- how do we keep our inner-light shining in the face of adversity. Performed in Italian, the power and pathos of the visual interpretation transcends language with a vivid, exhilarating production.

Key Points: 
  • NEW YORK, June 14, 2022 /PRNewswire/ -- The Rogue Theater Festival , New York City, in association with the Civica Scuola di Teatro Paolo Grassi in Milan, Italy announces production details of The Lantern Bearers by Marc Aronoff, a world premiere digital production.
  • Performed in Italian, the power and pathos of the visual interpretation transcends language with a vivid, exhilarating production.
  • Filmed in HD at Civica Scuola di Teatro Paolo Grassi in Milan, Italy, The Lantern Bearers is presented digitally in Italian and will be available for on-demand viewing from June 30th July 3rd, 2022.
  • Festivalof American Theater in Italy in partnership with the Civica Scuola Interpreti e Traduttori Altiero Spinelli e Civica Scuola di Teatro Paolo Grassiin Milan, Italy.

Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative

Retrieved on: 
Thursday, June 2, 2022

Civica, Inc. (Civica, Civica Rx) today announced the selection of Profil, Neuss, Germany, as its clinical trial partner to support the development of its affordable insulins.

Key Points: 
  • Civica, Inc. (Civica, Civica Rx) today announced the selection of Profil, Neuss, Germany, as its clinical trial partner to support the development of its affordable insulins.
  • Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes.
  • With its extensive experience and quality track record, Profil is the ideal clinical trial partner for Civica.
  • More information on Civica and its affordable insulin initiative, including commentary from partners and a fact sheet, can be found at https://civicainsulin.org .

Civica Announces Leadership Transition

Retrieved on: 
Tuesday, May 24, 2022

Civica, Inc. (Civica, Civica Rx) today announced that Ned McCoy, currently Civicas Chief Operating Officer, will succeed Martin VanTrieste as Civicas President and Chief Executive Officer, effective June 1.

Key Points: 
  • Civica, Inc. (Civica, Civica Rx) today announced that Ned McCoy, currently Civicas Chief Operating Officer, will succeed Martin VanTrieste as Civicas President and Chief Executive Officer, effective June 1.
  • As part of this transition, McCoy will also join the Civica Board of Directors on June 1.
  • Civica, Inc. (Civica, Civica Rx) is a nonprofit generic pharmaceutical company.
  • Hospital advisorsdoctors and pharmacistsprioritize the essential medicines Civica provides for use in acute and critical care, emergency rooms, and surgery.

Health Care Service Corporation Joins CivicaScript™ to Make Lower-Cost Generic Medicines Available to Its Members

Retrieved on: 
Monday, May 23, 2022

CivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and Health Care Service Corporation (HCSC), the nations largest customer-owned health insurer, announced today that HCSC is joining CivicaScript as a founding member.

Key Points: 
  • CivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and Health Care Service Corporation (HCSC), the nations largest customer-owned health insurer, announced today that HCSC is joining CivicaScript as a founding member.
  • Our mission is straightforward: to make quality generic medicines affordable and available for everyone, said CivicaScript President Gina Guinasso.
  • CivicaScript is the Civica, Inc. operating unit dedicated to lowering the cost of select high-cost generic medicines at the pharmacy counter.
  • Health Care Service Corporation is the country's largest customer-owned health insurer, with nearly 17.5 million members in its health plans in Illinois, Montana, New Mexico, Oklahoma and Texas.

Alcami Partners with Civica Rx in Multi-Year Agreement

Retrieved on: 
Tuesday, May 3, 2022

With the execution of this agreement, Alcami will provide analytical support for products to be manufactured at Civica's 140,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.

Key Points: 
  • With the execution of this agreement, Alcami will provide analytical support for products to be manufactured at Civica's 140,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
  • "We are proud to support Civica and the important work they are doing to ensure the supply of high-quality generic medicines in the United States," said Timothy Compton, Chief Business Officer of Alcami.
  • "Alcami will provide testing services for products developed and manufactured for and at our Civica Petersburg manufacturing facility," said Martin VanTrieste, President and CEO of Civica Rx.
  • Alcami's private equity ownership includes Madison Dearborn Partners and Ampersand Capital Partners.

JDRF Announces Support of Civica to Manufacture and Distribute Low-Cost Insulin

Retrieved on: 
Thursday, March 3, 2022

The project will manufacture and distribute three low-cost biosimilar insulin options to enable anyone to purchase insulin at no more than $30/vial and $55/box of five pens, regardless of insurance status.

Key Points: 
  • The project will manufacture and distribute three low-cost biosimilar insulin options to enable anyone to purchase insulin at no more than $30/vial and $55/box of five pens, regardless of insurance status.
  • "The Civica insulin development project is a tremendous step forward to make insulin accessible for all, regardless of insurance status, and address a national crisis," saidAaron Kowalski, Ph.D., JDRF CEO.
  • Hospital advisorsdoctors and pharmacistsprioritize the essential medicines Civica provides for use in acute and critical care, emergency rooms, and surgery.
  • Civica has since launched CivicaScript, focused on lowering prices at the pharmacy counter and The Civica Foundation, dedicated to fostering philanthropic support for manufacturing and distributing essential medicines.

Blue Shield of California Joins National Low-Cost Insulin Initiative to Help Make Life-Saving Medication More Affordable for Diabetes Patients

Retrieved on: 
Thursday, March 3, 2022

The insulin initiative is supported by a wide range of health systems and health plans, including Blue Shield of California and several other independent Blue Cross Blue Shield companies.

Key Points: 
  • The insulin initiative is supported by a wide range of health systems and health plans, including Blue Shield of California and several other independent Blue Cross Blue Shield companies.
  • "This initiative will put affordable insulin within reach of every Californian who needs it and help reduce healthcare spending driven by runaway prescription drug prices."
  • Blue Shield of California strives to create a healthcare system worthy of its family and friends that is sustainably affordable.
  • The company has contributed more than $500 million to Blue Shield of California Foundation since 2002 to have an impact on California communities.

Verinovum names An-Chan Phung Vice President of Product Strategy

Retrieved on: 
Wednesday, December 1, 2021

"An-Chan is a highly motivated and innovative executive with a proven record of product management, strategic leadership, and customer engagement. He brings extensive expertise to Verinovum, blending technical and commercial skills that will have a material impact on our organization's goals -- strategic, tactical, and operational," said Mike Noshay, Chief Strategy and Marketing Officer at Verinovum. "He is a well regarded public speaker in Master Data Management (MDM) and data quality, and can deliver complex messages simply and in a well thought out manner."

Key Points: 
  • TULSA, Okla., Dec. 1, 2021 /PRNewswire-PRWeb/ --Verinovum, a health data curation and enrichment technology company, has appointed An-Chan Phung as Vice President of Product Strategy.
  • Phung will align the strategic roadmap of Verinovum's solutions to the evolving needs of Verinovum's customers and partners.
  • He will intersect product strategy and technology by leading the organization's team toward achieving strategic initiatives and enhancing its technical vision.
  • "An-Chan is a highly motivated and innovative executive with a proven record of product management, strategic leadership, and customer engagement.

Half of Consumers Have Increased Digital Engagement with Businesses Since Start of Pandemic, with Preference for Video Chat Climbing 300%, Vonage Research Reveals

Retrieved on: 
Wednesday, November 10, 2021

Further, consumers preference for connecting with businesses using video has soared by 300 percent since January 2020, while preference for messaging apps such as WhatsApp, Facebook Messenger and Viber, has doubled.

Key Points: 
  • Further, consumers preference for connecting with businesses using video has soared by 300 percent since January 2020, while preference for messaging apps such as WhatsApp, Facebook Messenger and Viber, has doubled.
  • "COVID-19 has fundamentally changed how businesses operate and how consumers interact with those organisations," said Joy Corso, Chief Marketing Officer for Vonage.
  • Vonage explored some of the customer service hurdles that surveyed consumers reported and the business impact of these frustrations.
  • Video chat has become a mainstream addition to peoples everyday lives, with three-quarters of consumers using video to talk to friends and family.

Leading Health Systems Launch Graphite Health, a New Member-Led Non-Profit Company to Accelerate Digital Transformation of Health Care

Retrieved on: 
Tuesday, October 5, 2021

"The digital revolution that advanced every industry in the world missed health care," said Dr. Ries Robinson, CEO of Graphite Health and Chief Innovation Advisor at Presbyterian Healthcare Services.

Key Points: 
  • "The digital revolution that advanced every industry in the world missed health care," said Dr. Ries Robinson, CEO of Graphite Health and Chief Innovation Advisor at Presbyterian Healthcare Services.
  • By doing so, Graphite Health will accelerate access to valuable digital tools that can deliver better health care outcomes at a lower cost."
  • Graphite Health anticipates bringing additional health care systems and philanthropies into their coalition in the coming months, as well as partnering with leading technology innovators.
  • Graphite Health is a member-led company intent on transforming digital health care to improve patient outcomes and lower costs.